Funder
the National Natural Science Foundation of China
the Fundamental Research Funds for the Central Universities
the Natural Science Foundation Research Project of Shaanxi Province
the Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University
the national innovation experiment program for university students
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics
Reference22 articles.
1. Cheah BC, Vucic S, Krishnan AV, Kiernan MC (2010) Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17:1942–1959
2. Cheung YK, Gordon PH, Levin B (2006) Selective promising ALS therapies in clinical trials. Neurology 67:1748–1751
3. Chew DJ, Carlstedt T, Shortland PJ (2014) The effects of minocycline or riluzole treatment on spinal root avulsion-induced pain in adult rats. J Pain 5:664–675
4. Coleman N, Nguyen HM, Cao Z, Brown BM, Jenkins DP, Zolkowska D, Chen YJ, Tanaka BS, Goldin AL, Rogawski MA, Pessah IN (2015) The riluzole derivative 2-amino-6-trifluoromethylthiobenzothiazole (SKA-19), a mixed KCa2 activator and NaV blocker, is a potent novel anticonvulsant. Neurotherapeutics 12:234–249
5. Domino EF, Unna KR, Kerwin J (1952) Pharmacological properties of benzazoles. I. Relationship between structure and paralyzing action. J Pharmacol Exp Ther 105:486–497
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献